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generalised epidemics.13 We recommend that future versions 
of the ASSA model should also incorporate this capability 
of uncertainty analysis in order to present model estimates 
with 95% confidence bounds. This would greatly improve the 
comparison of ASSA outputs with empirical data from national 
population-based surveys.
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Professor Dorrington responds:
Three major concerns about the analysis and reporting of 
the latest HSRC results were raised in my article, namely the 
potential for bias (given the low response rates), the lack of 
acknowledgement of uncertainty in the results, and the use 
of the results from the 2002 survey as the basis for implying 
trend. None of these issues has been dealt with in a satisfactory 
manner by Rehle and Shisana.
Their response does not address the question of bias. 
However, through providing survey results not published 
in the report, they inadvertently provide grounds for further 
concern on this issue with their comparisons in Tables III and 
IV, which purport to show the similarity between estimates 
from the survey and those from the 2007 antenatal survey (to 
which they assume the 2008 survey will be ‘similar’). Bearing 
in mind the need for upward adjustment of the 2007 antenatal 
survey figures,1,2 both comparisons show the prevalence from 
the HSRC survey to be somewhat lower (2.7% lower than the 
correct figure for 20071,2 in the case of the black women aged 15 
- 49 years) than the figures with which the authors argue they 
should be comparable. Of course, given that probably around 
90%3 of those tested in the national antenatal sample are black 
women, one must wonder why the authors chose not to use the 
prevalence among pregnant black women in their comparisons, 
as in past surveys (instead of pregnant women in Table III and 
all black women in Table IV). 
The potential for bias is a crucial question deserving more 
debate. Arguments presented elsewhere by the authors (e.g. 
South African National AIDS Council and a UCT research 
seminar) that suggest that the survey is unbiased, either on the 
basis of research by Mishra and colleagues4,5 into this question 
with respect to household prevalence surveys carried out as 
part of the DHS surveys or on the basis of comparisons of the 
characteristics of the people who answered the questionnaire 
but did or did not agree to be tested, are problematic.
To the criticism that it would be more useful and honest 
to acknowledge the uncertainty and publish the confidence 
intervals, the authors’ response is that they regard 
‘epidemiological plausibility’ as being ‘more important’ 
than statistical significance. They argue that the decrease in 
prevalence among children aged 2 - 14, from an implausible 
5.6% in 2002 to a more sensible 2.5% in 2008, is ‘real’ based on 
the ‘contextual evidence’ that coverage of effective PMTCT 
programmes has increased. They present no quantitative 
evidence to explain how a programme preventing infection in 
infants and with low coverage between 2002 and 2005 might 
explain, in an ‘epidemiologically plausible’ way, that the bulk 
of the drop (5.6% to 3.3%) in prevalence among children aged  
2 - 14 occurred between 2002 and 2005!
Similarly they argue that the drop in prevalence in the 
youth is plausible in the light of their ‘reported substantive 
behavioural changes’. Ignoring the question about whether 
reported behaviour is actual behaviour, it is curious that the 
reported drop in knowledge (also statistically significant) in the 
youth, the increase in percentage of males with more than one 
partner in the past year, and the fall in the age of sexual debut 
of males are not mentioned as indicators of changes in sexual 
behaviour. 
Furthermore, the argument that comparing the trend in 
prevalence in 15 - 19-year-olds as measured by the survey with 
the trend in the prevalence of 15 - 19-year-olds attending public 
antenatal clinics is ‘like comparing apples and oranges’ misses 
the point. If condoms are being used to prevent the spread of 
the disease and are the major source of contraception, then: 
(i) one would expect to see a change in the age distribution of 
women attending public antenatal clinics (which one doesn’t 
see); and, more importantly, (ii) if the prevalence in young 
women is falling to the extent suggested by the report, then 
surely one would have expected to see the prevalence among 
pregnant women (as measured by the antenatal survey) falling 
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too (which it doesn’t appear to be doing). Unless, of course, 
the suggestion is that prevalence is only falling in women who 
wouldn’t have fallen pregnant had they had unprotected sex! 
Finally, of the concern that 2002 is used as a basis for 
inferring trend the authors point out, quite correctly, that the 
change in prevalence from the HSRC survey shown in Table 
III of the article is that for the population aged 2 and older, 
whereas it would be more appropriate to consider the change 
in prevalence for the population aged 15 - 49. However, they 
fail to remedy this error, described by them as ‘some serious 
inaccuracies’, by providing the figures for women aged 15 - 49, 
preferring to argue that the trend implied by differencing the 
prevalence rates from the 2002 and 2008 surveys is ‘in good 
agreement’ with the trend from the antenatal surveys on the 
grounds that 6 of the 9 provinces showed change in the same 
direction. Aside from the fact that the chances of getting such a 
result or better are about 75% if one allocates the up and down 
arrows randomly, their comparison misses the point. It was the 
conclusion, based on the comparison from 2002 that prevalence 
had dropped in 4 provinces, which was at issue. The table with 
the correct figures is reproduced below (Table I). It is interesting 
to note that not only do the corrected figures not change the 
argument, but in the case of 2 of the 4 provinces (Western Cape 
and Gauteng) the differences are even more marked.
Rehle and Shisana also argue that change in overall 
prevalence over the period of the two surveys is very similar. 
The problems with this argument are: (i) as mentioned in the 
footnote to Table I there was a significant change in the sample 
used by the antenatal survey in 2006 and this, if anything, 
probably leads to an underestimate of the trend between 2002 
and 2007; and (ii) the prevalence in 2007 that is comparable to 
the 2002 figure is not 28.0% but 29.3%,1,2 and hence the implied 
increase in prevalence in women attending public antenatal 
clinics is at least 2.8% (which is a good deal higher than the 
1.3% they report for the national household prevalence survey).
It should be noted that none of the points above have been 
argued on the basis of a model (ASSA’s or otherwise). My 
purpose was not to argue that models are better than empirical 
data or that the HSRC survey is wrong (at least not in any way 
that suggested fault on the part of the investigators) or that 
PMTCT and ARV aren’t having an effect or that behaviour 
is not changing towards the less risky, but to suggest that 
interpretation of the results should be more cautious and 
scientific and prepared to acknowledge the limitations of the 
survey.
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Table I. Difference in prevalence (%), 15 - 49 years, HSRC 
(2002 - 2008) v. antenatal surveys (2002 - 2007)
  HSRC survey Antenatal  survey
Province  (2002 - 2008) (2002 - 2007)*
Western Cape          –7.9           +2.9
Northern Cape          –0.6           +1.5
Free State           –0.9           +2.7
Gauteng           –5.1           –1.0
*These values ignore the impact of the expansion of the sample in 2006 which if 
allowed for would probably increase these differences by at least 1% and by as much 
as 3% for the Northern Cape in particular.
